Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof
Patent 5972919 Issued on October 26, 1999. Estimated Expiration Date: 
October 7, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 7, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesCompositions and method of treating with stereoisomeric mixtures of 2-unsymmetrical 16,17-methylenedioxy steroids -Aminomethylbenzyl alcohol derivatives Patent #: 3994974 InventorsAssigneeApplicationNo. 944683 filed on 10/07/1997US Classes:514/171, With additional active ingredient514/174, -O-C-O- is part of a hetero ring (e.g., acetonide, etc.)514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/826ASTHMAExaminersPrimary: Henley, III, RaymondAttorney, Agent or FirmForeign Patent References
International ClassesA61K 031/56A61K 031/135 Foreign Application Priority Data1991-12-18 EPAbstractEffective amounts of formoterol (and/or a physiologically acceptable salt and/or solvate thereof) and budesonide are used in combination for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorder.Other References
| |
